CSG's Tank Ambitions Clash With Delivery Dispute as Earnings Test Looms

CSG's new Karpat tank targets Slovak tender, but Caesar howitzer dispute and short-seller report weigh on stock, down 51% from highs, ahead of first post-IPO earnings.

The Czechoslovak Group is living a split-screen reality. One side of the business is rolling out a brand-new battle tank aimed at winning a major Slovak procurement, while the other is locked in a delivery dispute over 62 Caesar howitzers destined for the Czech military. For investors, the question is which narrative will dominate when the company reports its first post-IPO quarterly earnings next week.

Shares of CSG closed at €16.42 on Friday, trimming the week's gain to 2.75% but leaving a brutal monthly loss of 22.7% intact. The stock now trades roughly 51% below its January high, a rout that analysts attribute to operational setbacks and a damaging short-seller report rather than any fundamental deterioration in the group's core business.

Karpat Debut Signals Strategic Pivot

On the product front, CSG used this week's IDEB defence exhibition in Bratislava to unveil the CFL-120 Karpat, a medium tank developed in partnership with Turkey's FNSS and Italy's Leonardo. Weighing over 30 tonnes — the secondary source puts it at exactly 34 tonnes — the vehicle carries a 105/120-mm cannon and is designed for rapid deployment in Central and Eastern Europe.

The Karpat is more than a new platform. It represents CSG's ambition to evolve from a munitions supplier into an integrated land-systems builder. The company is pitching the tank for a potential Slovak tender that could cover up to 108 vehicles, with production to be anchored in both the Czech Republic and Slovakia. BAE Systems Hägglunds is expected to compete with its CV90120.

Caesar Howitzer Crisis Weighs on Cash Flow

The glossy launch stands in stark contrast to the mess surrounding CSG's Caesar artillery contract. The company's Excalibur Army subsidiary was supposed to deliver 62 Caesar howitzers to the Czech Defence Ministry under a deal valued at roughly 10.3 billion Czech crowns. Four units were due by April 2026.

Military tests have yet to begin. KNDS, the howitzer's manufacturer, says prototypes have been ready since summer 2025, but the ministry has demanded a halt to deliveries, citing unresolved defects. The financial exposure is significant: Prague has already paid around 7 billion crowns. For CSG, the delay locks up working capital, pushes back revenue recognition, and risks souring one of its most important customer relationships.

Short-Seller Attack and Analyst Defence

The stock's slide accelerated in early May after Hunterbrook Media published a report alleging that CSG merely refurbishes old ammunition stocks. The attack triggered a heavy sell-off, but analysts have held firm. All nine covering the stock rate it a buy, with JPMorgan setting a price target of €40 — more than double the current level.

The fundamental case rests on numbers that remain robust. Revenue surged last year, the order book stands at €42 billion, and management has reiterated its 2026 guidance for an operating margin of around 24%. The question is whether execution risk — particularly on the Caesar contract — will erode confidence before those earnings materialise.

Two Deadlines, One Reckoning

The next major catalyst arrives on May 20, when CSG releases its first quarterly report since listing. That filing will reveal the one-time costs of the IPO and, more importantly, show how much cash the Caesar dispute is tying up. Investors will scrutinise advance payments, working capital movements and any updated timeline on the Czech deliveries.

A second deadline falls at the end of May, when Slovakia's window under the European SAFE programme for cheap financing expires. If Bratislava cannot secure a partner state by then, borrowing costs could rise and future CSG orders in the region could slip. Between the earnings release and the SAFE deadline, the next two weeks will tell the market whether the Karpat tank can become a genuine growth story — or whether the howitzer headache will define the stock for the rest of the year.